SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals - Quaterly Results

23 May 2026 Evaluate
A slight decline in the revenue of Rs. 2379.48 millions was seen for the March 2026 quarter as against Rs. 2481.96 millions during year-ago period.Net profit for the quarter ended March 2026 increases to Rs. 209.20  millions from Rs. 206.23 millions.Operating Profit reported a sharp decline to 424.53 millions from 427.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 2379.48 2481.96 -4.13 8868.71 7827.48 13.30 8868.71 7827.48 13.30
Other Income 25.74 14.24 80.76 83.54 62.24 34.22 83.54 62.24 34.22
PBIDT 424.53 427.70 -0.74 1792.67 1461.98 22.62 1792.67 1461.98 22.62
Interest 52.77 50.65 4.19 230.76 185.41 24.46 230.76 185.41 24.46
PBDT 371.76 377.05 -1.40 1561.91 1276.57 22.35 1561.91 1276.57 22.35
Depreciation 101.31 86.40 17.26 399.19 343.37 16.26 399.19 343.37 16.26
PBT 270.45 290.65 -6.95 1162.72 933.20 24.59 1162.72 933.20 24.59
TAX 61.25 84.42 -27.45 286.62 249.39 14.93 286.62 249.39 14.93
Deferred Tax 6.92 37.92 -81.75 27.29 52.99 -48.50 27.29 52.99 -48.50
PAT 209.20 206.23 1.44 876.10 683.81 28.12 876.10 683.81 28.12
Equity 93.65 88.65 5.64 93.65 88.65 5.64 93.65 88.65 5.64
PBIDTM(%) 17.84 17.23 3.53 20.21 18.68 8.22 20.21 18.68 8.22

SMS Pharmaceuticals Share Price

353.80 -2.50 (-0.70%)
04-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.35
Dr. Reddys Lab 1267.05
Cipla 1397.75
Zydus Lifesciences 1085.45
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×